Literature DB >> 26622069

In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles.

Yun Hu1, Zongmin Zhao1, Marion Ehrich2, Kristel Fuhrman3, Chenming Zhang1.   

Abstract

A hybrid nanoparticle (NP) consisting of a pH sensitive lipid shell and a poly(lactic-co-glycolic) acid (PLGA) core was constructed. This hybrid NP has a mean size of 120.1 ± 8.8 nm and positively charged surface (zeta potential of 14.2 ± 1.4 mV). The lipid shell of the hybrid NP was quickly disintegrated in buffer with a pH of 5.5, which resembles the acidic environment of endosomes in dendritic cell (DC). Less than 20% of the antigen enclosed in pH-sensitive hybrid NP was released into human serum at physiological pH within 24 h, but more than 40% of the enclosed antigen was released within 8 h after pH was adjusted to 5.5. Fast uptake of the pH sensitive hybrid NP by DC was also observed. It was found that pH sensitive hybrid NP displayed faster degradation and antigen release compared to regular hybrid NPs after uptake by DC.

Entities:  

Keywords:  PLGA nanoparticle; Vaccine; pH-sensitive lipid

Year:  2015        PMID: 26622069      PMCID: PMC4662652          DOI: 10.1016/j.polymer.2015.10.048

Source DB:  PubMed          Journal:  Polymer (Guildf)        ISSN: 0032-3861            Impact factor:   4.430


  31 in total

1.  Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.

Authors:  Shyh-Dar Li; Leaf Huang
Journal:  J Control Release       Date:  2010-03-23       Impact factor: 9.776

Review 2.  Improving vaccines by targeting antigens to dendritic cells.

Authors:  Ken Shortman; Mireille H Lahoud; Irina Caminschi
Journal:  Exp Mol Med       Date:  2009-02-28       Impact factor: 8.718

Review 3.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

Review 4.  Current adjuvants and new perspectives in vaccine formulation.

Authors:  Emanuele Montomoli; Simona Piccirella; Baharak Khadang; Elisa Mennitto; Roberto Camerini; Alfonso De Rosa
Journal:  Expert Rev Vaccines       Date:  2011-07       Impact factor: 5.217

Review 5.  Functional PLGA NPs for oral drug delivery: recent strategies and developments.

Authors:  L Martin-Banderas; M Durán-Lobato; I Muñoz-Rubio; J Alvarez-Fuentes; M Fernández-Arevalo; M A Holgado
Journal:  Mini Rev Med Chem       Date:  2013-01       Impact factor: 3.862

6.  Biodegradable particles as vaccine delivery systems: size matters.

Authors:  Vijaya B Joshi; Sean M Geary; Aliasger K Salem
Journal:  AAPS J       Date:  2012-10-10       Impact factor: 4.009

7.  Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing.

Authors:  Pedro M Valencia; Pamela A Basto; Liangfang Zhang; Minsoung Rhee; Robert Langer; Omid C Farokhzad; Rohit Karnik
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

8.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

Authors:  Liangfang Zhang; Juliana M Chan; Frank X Gu; June-Wha Rhee; Andrew Z Wang; Aleksandar F Radovic-Moreno; Frank Alexis; Robert Langer; Omid C Farokhzad
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

Review 9.  Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.

Authors:  Susana Martins; Bruno Sarmento; Domingos C Ferreira; Eliana B Souto
Journal:  Int J Nanomedicine       Date:  2007

Review 10.  Nanoparticle-based vaccine delivery for cancer immunotherapy.

Authors:  Yeong-Min Park; Seung Jun Lee; Young Seob Kim; Moon Hee Lee; Gil Sun Cha; In Duk Jung; Tae Heung Kang; Hee Dong Han
Journal:  Immune Netw       Date:  2013-10-26       Impact factor: 6.303

View more
  8 in total

Review 1.  Stimuli-responsive liposomes for drug delivery.

Authors:  Y Lee; D H Thompson
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-15

2.  Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation.

Authors:  Mengyuan Zhang; Jianhua He; Wenli Zhang; Jianping Liu
Journal:  Pharm Res       Date:  2018-08-30       Impact factor: 4.200

3.  Effect of Adjuvant Release Rate on the Immunogenicity of Nanoparticle-Based Vaccines: A Case Study with a Nanoparticle-Based Nicotine Vaccine.

Authors:  Zongmin Zhao; Yun Hu; Theresa Harmon; Paul Pentel; Marion Ehrich; Chenming Zhang
Journal:  Mol Pharm       Date:  2019-05-22       Impact factor: 4.939

4.  Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization.

Authors:  Zongmin Zhao; Yun Hu; Theresa Harmon; Paul Pentel; Marion Ehrich; Chenming Zhang
Journal:  Biomaterials       Date:  2017-05-19       Impact factor: 12.479

5.  The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine.

Authors:  Yun Hu; Daniel Smith; Evan Frazier; Reece Hoerle; Marion Ehrich; Chenming Zhang
Journal:  Biomaterials       Date:  2016-08-18       Impact factor: 12.479

6.  Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines.

Authors:  Yun Hu; Zongmin Zhao; Theresa Harmon; Paul R Pentel; Marion Ehrich; Chenming Zhang
Journal:  Biomaterials       Date:  2018-08-07       Impact factor: 12.479

7.  Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins.

Authors:  Zongmin Zhao; Yun Hu; Theresa Harmon; Paul R Pentel; Marion Ehrich; Chenming Zhang
Journal:  Nanomedicine       Date:  2018-04-30       Impact factor: 5.307

8.  X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs.

Authors:  Sandhya Clement; Wenjie Chen; Wei Deng; Ewa M Goldys
Journal:  Int J Nanomedicine       Date:  2018-06-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.